R

RayzeBio

74 employees

RayzeBio is a pharmaceuticals company that develops targeted radiopharmaceutical drugs for cancer.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Medical Device
Health Care
Pharmaceutical

Date founded

2020

Funding rounds raised

Total raised

$160M

from 25 investors over 25 rounds

R

RayzeBio raised $160M on September 13, 2022

Investors: Laurion Capital Management LP, Sands Capital Management, Viking Global Investors, Sofinnova Ventures, Russia technology fund, Soleus Capital Management, L.P. and Wellington Management

R

RayzeBio raised $108M on June 15, 2021

Investors: TCG X, Vivo Capital, Viking Global Investors, OrbiMed Advisors, Samsara BioCapital, Versant Ventures, Redmile Group, venBio Partners and Perceptive Advisors

R

RayzeBio raised $105M on December 8, 2020

Investors: Samsara BioCapital, Versant Ventures, Logos Global Management, LP, OrbiMed Advisors, LifeSci Venture Partners, venBio Partners and Redmile Group

R

RayzeBio raised $45M on October 14, 2020

Investors: Samsara BioCapital, venBio Partners and Versant Ventures

FAQ